Manel Esteller graduated in Medicine from the Universitat de Barcelona in 1992, where he also obtained his Ph.D. degree specialising in molecular genetics in 1996. From 1997 to 2001, Esteller was a Postdoctoral Fellow and a Research Associate at Johns Hopkins where he studied DNA methylation and human cancer. His work was decisive in establishing promoter hypermethylation of tumor suppressor genes as a common hallmark of cancer. From 2001 to 2008 Manel Esteller was the Leader of the CNIO Cancer Epigenetics Laboratory. Dr Esteller is the Director of the Cancer Epigenetics and Biology Program (PEBC) of the Bellvitge Institute for Biomedical Research (IDIBELL) in Barcelona, Professor of Genetics in the University of Barcelona, and an ICREA Research Professor. His current research is devoted to the establishment of the epigenome maps, the study of the interactions between epigenetic modifications and non-coding RNAs, and the development of new epigenetic drugs. Author of more than four hundred fifty original peer-reviewed manuscripts in biomedical sciences, he is also a Member of numerous international scientific societies, Editorial Boards and reviewer for many journals and funding agencies. His work has received, among other, the Carcinogenesis Award, Swiss Bridge Award, DEbiopharm-EPFL Award, Dr. Josef Steiner Cancer Research Award, World Health Summit Award and Severo Ochoa Award.
« Go Back